Wednesday, February 8, 2012

You are here: Home / Intellectual Property / Court Vacates PTO Denial of Angiomax Patent Term Extension; PTO Says No Again
Subscribe to the IP Headline RSS feed | Subscribe to the IP Headline feed via Email

Court Vacates PTO Denial of Angiomax Patent Term Extension; PTO Says No Again

March 26, 2010 in Patent Trademark & Copyright Journal · Leave a Comment 

In a long-sought but short-lived victory for Medicines Co., the U.S. District Court for the Eastern District of Virginia March 16 set aside the Patent and Trademark Office’s refusal to extend the patent term covering the company’s anticoagulant drug Angiomax (bivalirudin) (Medicines Co. v. Kappos, E.D. Va., No. 1:10-cv-00081-CMH-TCB, 3/16/10).

  1. Read this entire article for free, simply activate your free 15 day trial access to Patent Trademark & Copyright Journal now.
Patent Trademark & Copyright Journal
  3. (required)
  4. (required)
  5. (valid email required)
  6. (required)
  7. (required)
  8. (required)
  10. (required)
  11. (required)
  12. (required)
  13. (required)
  14. Captcha
 

cforms contact form by delicious:days

Filed under Intellectual Property · Tagged with ,

Comments

Please feel free to comment on this article...
You can obtain a picture to go with your comment at gravatar!